Recombinant human non-glycosylated erythropoietin (rh-ngEpo) expressed in E. coli was attached to polyethylene glycol (PEG) chains with different sizes and structures. The pharmacokinetic properties and in vivo potency of the PEGylated protein were investigated and comparisons were drawn between the conjugates and glycosylated recombinant Epo (rhEpo)
Stability of erythropoietin (EPO) depends on its glycosylation states. With more glycosylation sites...
PEGylation defines the modification of a protein, peptide or non-peptide molecule by the linking of ...
Context: The recombinant human erythropoietin (rHuEPO) stimulates the erythropoiesis process. Becaus...
Recombinant human erythropoietin produced by mammalian cells contains about 40% carbohydrates which ...
Recombinant human erythropoietin (rhEpo) is a glycoprotein expressed in Chinese hamster ovary (CHO) ...
The covalent attachment of polyethylene glycol (PEG) to therapeutic proteins can improve their physi...
临床用重组人促红细胞生成素(rhEpo)是中国仓鼠卵巢细胞(Chinese hamster ovary cell,CHO)表达的糖蛋白,糖基对稳定蛋白的结构和生物活性非常重要,但CHO表达体系生产成本...
Erythropoietin (EPO) is the principal hormone which, has somewhat short half-life involved in the di...
Erythropoietin (EPO) plays a key regulatory role in the formation of new red blood cells (RBCs). Ery...
Human erythropoietin (hEpo) is an essential regulator of erythrocyte production that induces the div...
Physicochemical and biological properties of recombinant human erythropoietin (rhEPO) were compared ...
Proteins have gained an important role in clinical practice, and they are the treatment of choice or...
By now the pegylation of biologically active molecules including proteins with an inert hydrophilic ...
Hadi Mirzaei,1 Bahram Kazemi,1 Mojgan Bandehpour,1 Alireza Shoari,2 Vahid Asgary,2 Mehdi Shafiee Ard...
Peptide and protein PEGylation is usually undertaken to improve the biopharmaceutical properties of ...
Stability of erythropoietin (EPO) depends on its glycosylation states. With more glycosylation sites...
PEGylation defines the modification of a protein, peptide or non-peptide molecule by the linking of ...
Context: The recombinant human erythropoietin (rHuEPO) stimulates the erythropoiesis process. Becaus...
Recombinant human erythropoietin produced by mammalian cells contains about 40% carbohydrates which ...
Recombinant human erythropoietin (rhEpo) is a glycoprotein expressed in Chinese hamster ovary (CHO) ...
The covalent attachment of polyethylene glycol (PEG) to therapeutic proteins can improve their physi...
临床用重组人促红细胞生成素(rhEpo)是中国仓鼠卵巢细胞(Chinese hamster ovary cell,CHO)表达的糖蛋白,糖基对稳定蛋白的结构和生物活性非常重要,但CHO表达体系生产成本...
Erythropoietin (EPO) is the principal hormone which, has somewhat short half-life involved in the di...
Erythropoietin (EPO) plays a key regulatory role in the formation of new red blood cells (RBCs). Ery...
Human erythropoietin (hEpo) is an essential regulator of erythrocyte production that induces the div...
Physicochemical and biological properties of recombinant human erythropoietin (rhEPO) were compared ...
Proteins have gained an important role in clinical practice, and they are the treatment of choice or...
By now the pegylation of biologically active molecules including proteins with an inert hydrophilic ...
Hadi Mirzaei,1 Bahram Kazemi,1 Mojgan Bandehpour,1 Alireza Shoari,2 Vahid Asgary,2 Mehdi Shafiee Ard...
Peptide and protein PEGylation is usually undertaken to improve the biopharmaceutical properties of ...
Stability of erythropoietin (EPO) depends on its glycosylation states. With more glycosylation sites...
PEGylation defines the modification of a protein, peptide or non-peptide molecule by the linking of ...
Context: The recombinant human erythropoietin (rHuEPO) stimulates the erythropoiesis process. Becaus...